Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Heim

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Gastroenterology|September 20, 2011
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infectionStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Lancet (London, England)|October 7, 2016
Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trialStefan J Schaller, Matthew Anstey, Manfred Blobner, et al.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Immunity|December 19, 2024
The carbonyl nucleobase adduct M<sub>3</sub>Ade is a potent antigen for adaptive polyclonal MR1-restricted T cellsAndrew Chancellor, Daniel Constantin, Giuliano Berloffa, et al.
Journal of Hepatology|January 16, 2025
Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emergesAnne Geng, Robert G Brenig, Julien Roux, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Critical Care (London, England)|June 28, 2022
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenationJohannes Herrmann, Christopher Lotz, Christian Karagiannidis, et al.
JAMA Surgery|December 20, 2023
Preoperative Midazolam and Patient-Centered Outcomes of Older Patients: The I-PROMOTE Randomized Clinical TrialAna Kowark, András P Keszei, Gerhard Schneider, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 2, 2023
AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate CellsOltin-Tiberiu Pop, Anne Geng, Emilio Flint, et al.
Critical Care Medicine|December 9, 2025
Multicenter Evaluation of an Interoperable System for Automated Guideline Adherence Monitoring in ICUsGregor Lichtner, Fridtjof Schiefenhövel, Bora Gashi, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Gastroenterology|September 20, 2011
Efficacy of the protease inhibitor BI 201335, polymerase inhibitor BI 207127, and ribavirin in patients with chronic HCV infectionStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Lancet (London, England)|October 7, 2016
Early, goal-directed mobilisation in the surgical intensive care unit: a randomised controlled trialStefan J Schaller, Matthew Anstey, Manfred Blobner, et al.
Antiviral Therapy|April 6, 2013
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final resultsStefan Zeuzem, Tarik Asselah, Peter Angus, et al.
Immunity|December 19, 2024
The carbonyl nucleobase adduct M<sub>3</sub>Ade is a potent antigen for adaptive polyclonal MR1-restricted T cellsAndrew Chancellor, Daniel Constantin, Giuliano Berloffa, et al.
Journal of Hepatology|January 16, 2025
Circulating monocytes upregulate CD52 and sustain innate immune function in cirrhosis unless acute decompensation emergesAnne Geng, Robert G Brenig, Julien Roux, et al.
Gastroenterology|January 12, 2010
Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association studyAndri Rauch, Zoltán Kutalik, Patrick Descombes, et al.
Critical Care (London, England)|June 28, 2022
Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenationJohannes Herrmann, Christopher Lotz, Christian Karagiannidis, et al.
JAMA Surgery|December 20, 2023
Preoperative Midazolam and Patient-Centered Outcomes of Older Patients: The I-PROMOTE Randomized Clinical TrialAna Kowark, András P Keszei, Gerhard Schneider, et al.
Cellular and Molecular Gastroenterology and Hepatology|April 2, 2023
AXL Expression on Homeostatic Resident Liver Macrophages Is Reduced in Cirrhosis Following GAS6 Production by Hepatic Stellate CellsOltin-Tiberiu Pop, Anne Geng, Emilio Flint, et al.
Critical Care Medicine|December 9, 2025
Multicenter Evaluation of an Interoperable System for Automated Guideline Adherence Monitoring in ICUsGregor Lichtner, Fridtjof Schiefenhövel, Bora Gashi, et al.
Pageof 7